How Can I Help?

Enter Amount:

ALS News from Yahoo!
lou gehrig disease, amyotrophic lateral sclerosis - Yahoo News Search Results
lou gehrig disease, amyotrophic lateral sclerosis - Yahoo News Search Results

  • Scientists Make Gene Discovery in Lou Gehrig's Disease
    Title: Scientists Make Gene Discovery in Lou Gehrig's Disease Category: Health News Created: 4/1/2014 9:35:00 AM Last Editorial Review: 4/1/2014 12:00:00 AM

  • Unraveling tangled origin of amyotrophic lateral sclerosis (ALS)
    By studying nerve cells that originated in patients with a severe neurological disease, a researcher has pinpointed an error in protein formation that could be the root of amyotrophic lateral sclerosis. Also called Lou Gehrig's disease, ALS causes paralysis and death. According to the ALS Association, as many as 30,000 Americans are living with ALS.

  • Study identifies key player in motor neuron death in Lou Gehrig's disease
    ( Nationwide Children's Hospital ) Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, is marked by a cascade of cellular and inflammatory events that weakens and kills vital motor neurons in the brain and spinal cord. The process is complex, involving cells that ordinarily protect the neurons from harm. Now, a new study by scientists in the Research Institute at Nationwide ...

  • Patient stem cells help identify common problem in ALS
    A recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis -- Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder, new stem cell research has shown. The researchers are now designing an initial clinical trial testing the safety of the treatment in ALS patients.

  • Study points to potential culprit that kills motor neurons in ALS
    Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, is marked by a cascade of cellular and inflammatory events that weakens and kills vital motor neurons in the brain and spinal cord. The process is complex, involving cells that ordinarily protect the neurons from harm. Now, a new study by scientists in The Research Institute at Nationwide Children's Hospital points to a potential ...

  • Boomers to Take on Les Turner All-Stars in Charity Game May 12
    SCHAUMBURG, Ill. - Highlighted by the game on Monday, May 12 at 6:30 p.m. to benefit the Les Turner ALS Foundation's battle against Lou Gehrig's disease, the Schaumburg Boomers announced their eight-game exhibition schedule as the franchise's defense of the 2013 Frontier League Championship officially kicks off on Friday, May 23 with a 6:30 p.m. tilt against the Florence Freedom.

  • Neuralstem Principal Investigator, Dr. Eva Feldman, To Present Published ALS Trial Phase I Data At Medical Conference
    ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell trial in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) will present Phase I data at the...

  • UW-Madison researcher discovers possible cause of Lou Gehrig?s disease
    University of Wisconsin-Madison researcher Su-Chun Zhang has found an error in protein formation that could be the root of Lou Gehrig?s disease, according to a university release.

  • New ALS Gene Strengthens Focus on RNA Processing
    WASHINGTON, March 31, 2014 /PRNewswire-USNewswire/ -- In work supported by The ALS Association, researchers have discovered a new ALS-causing gene and have linked its function to that of another prominent disease gene. ALS (amyotrophic lateral sclerosis), otherwise known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects neurons (nerve cells) in the brain and the ...

  • Harvard stem cell scientists discover potential treatment for amyotrophic lateral sclerosis
    Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS ...